Literature DB >> 29774543

Human monocyte transcriptional profiling identifies IL-18 receptor accessory protein and lactoferrin as novel immune targets in hypertension.

Matthew R Alexander1, Allison E Norlander2, Fernando Elijovich3, Ravi V Atreya4, Amadou Gaye5, Juan S Gnecco6, Cheryl L Laffer3, Cristi L Galindo1, Meena S Madhur1,2,3.   

Abstract

BACKGROUND AND
PURPOSE: Monocytes play a critical role in hypertension. The purpose of our study was to use an unbiased approach to determine whether hypertensive individuals on conventional therapy exhibit an altered monocyte gene expression profile and to perform validation studies of selected genes to identify novel therapeutic targets for hypertension. EXPERIMENTAL APPROACH: Next generation RNA sequencing identified differentially expressed genes in a small discovery cohort of normotensive and hypertensive individuals. Several of these genes were further investigated for association with hypertension in multiple validation cohorts using qRT-PCR, regression analysis, phenome-wide association study and case-control analysis of a missense polymorphism. KEY
RESULTS: We identified 60 genes that were significantly differentially expressed in hypertensive monocytes, many of which are related to IL-1β. Uni- and multivariate regression analyses of the expression of these genes with mean arterial pressure (MAP) revealed four genes that significantly correlated with MAP in normotensive and/or hypertensive individuals. Of these, lactoferrin (LTF), peptidoglycan recognition protein 1 and IL-18 receptor accessory protein (IL18RAP) remained significantly elevated in peripheral monocytes of hypertensive individuals in a separate validation cohort. Interestingly, IL18RAP expression associated with MAP in a cohort of African Americans. Furthermore, homozygosity for a missense single nucleotide polymorphism in LTF that decreases antimicrobial function and increases protein levels (rs1126478) was over-represented in patients with hypertension relative to controls (odds ratio 1.16). CONCLUSIONS AND IMPLICATIONS: These data demonstrate that monocytes exhibit enhanced pro-inflammatory gene expression in hypertensive individuals and identify IL18RAP and LTF as potential novel mediators of human hypertension. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29774543      PMCID: PMC6534784          DOI: 10.1111/bph.14364

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

1.  Incidence and predictors of hypertension over 8 years among Chinese men and women.

Authors:  Dongfeng Gu; Rachel P Wildman; Xiqui Wu; Kristi Reynolds; Jianfeng Huang; Chung-Shiuan Chen; Jiang He
Journal:  J Hypertens       Date:  2007-03       Impact factor: 4.844

2.  Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality.

Authors:  George Davey Smith; Debbie A Lawlor; Roger Harbord; Nic Timpson; Ann Rumley; Gordon D O Lowe; Ian N M Day; Shah Ebrahim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

3.  Preactivated peripheral blood monocytes in patients with essential hypertension.

Authors:  Y Dörffel; C Lätsch; B Stuhlmüller; S Schreiber; S Scholze; G R Burmester; J Scholze
Journal:  Hypertension       Date:  1999-07       Impact factor: 10.190

4.  Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?

Authors:  Y Dörffel; S Franz; A Pruss; G Neumann; W Rohde; G R Burmester; J Scholze
Journal:  Atherosclerosis       Date:  2001-07       Impact factor: 5.162

5.  A prospective study of body mass index and the risk of developing hypertension in men.

Authors:  Rebecca P Gelber; J Michael Gaziano; JoAnn E Manson; Julie E Buring; Howard D Sesso
Journal:  Am J Hypertens       Date:  2007-04       Impact factor: 2.689

6.  Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice.

Authors:  Roman Dziarski; Kenneth A Platt; Eva Gelius; Håkan Steiner; Dipika Gupta
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

7.  Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis.

Authors:  Masaaki Iigo; Mariko Shimamura; Eiji Matsuda; Ken-ichi Fujita; Hiroshi Nomoto; Jun Satoh; Syuji Kojima; David B Alexander; Malcolm A Moore; Hiroyuki Tsuda
Journal:  Cytokine       Date:  2004-01-07       Impact factor: 3.861

8.  Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status.

Authors:  José Maria Moreno-Navarrete; Francisco José Ortega; Judit Bassols; Antoni Castro; Wifredo Ricart; José Manuel Fernández-Real
Journal:  Clin Chem       Date:  2007-12-21       Impact factor: 8.327

9.  Glucocorticoid sensitivity of circulating monocytes in essential hypertension.

Authors:  Petra H Wirtz; Roland von Känel; Karl Frey; Ulrike Ehlert; Joachim E Fischer
Journal:  Am J Hypertens       Date:  2004-06       Impact factor: 2.689

10.  Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin.

Authors:  W P Wang; M Iigo; J Sato; K Sekine; I Adachi; H Tsuda
Journal:  Jpn J Cancer Res       Date:  2000-10
View more
  14 in total

1.  From Rags to Riches: Moving Beyond RAG1 in Studies of Hypertension.

Authors:  Meena S Madhur; Annet Kirabo; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2020-02-10       Impact factor: 10.190

2.  Immunity and hypertension: New targets to lighten the pressure.

Authors:  Antony Vinh; Grant R Drummond; Christopher G Sobey
Journal:  Br J Pharmacol       Date:  2019-06       Impact factor: 8.739

Review 3.  Inflammation in Hypertension.

Authors:  Liang Xiao; David G Harrison
Journal:  Can J Cardiol       Date:  2020-01-24       Impact factor: 5.223

Review 4.  Epigenetic Mechanisms Involved in Inflammaging-Associated Hypertension.

Authors:  Vinícius Augusto Simão; León Ferder; Walter Manucha; Luiz Gustavo A Chuffa
Journal:  Curr Hypertens Rep       Date:  2022-07-07       Impact factor: 4.592

Review 5.  Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer's disease.

Authors:  Ekta Bajwa; Andis Klegeris
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 6.  Innate immunity and clinical hypertension.

Authors:  Justin P Van Beusecum; Hietor Moreno; David G Harrison
Journal:  J Hum Hypertens       Date:  2021-10-23       Impact factor: 2.877

7.  Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.

Authors:  Asif Nashiry; Shauli Sarmin Sumi; Salequl Islam; Julian M W Quinn; Mohammad Ali Moni
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

Review 8.  Salt Sensitivity of Blood Pressure in Blacks and Women: A Role of Inflammation, Oxidative Stress, and Epithelial Na+ Channel.

Authors:  Melis Sahinoz; Fernando Elijovich; Lale A Ertuglu; Jeanne Ishimwe; Ashley Pitzer; Mohammad Saleem; Naome Mwesigwa; Thomas R Kleyman; Cheryl L Laffer; Annet Kirabo
Journal:  Antioxid Redox Signal       Date:  2021-12-20       Impact factor: 8.401

Review 9.  Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

Authors:  Meena S Madhur; Fernando Elijovich; Matthew R Alexander; Ashley Pitzer; Jeanne Ishimwe; Justin P Van Beusecum; David M Patrick; Charles D Smart; Thomas R Kleyman; Justin Kingery; Robert N Peck; Cheryl L Laffer; Annet Kirabo
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

10.  Angiotensinogen and interleukin 18 in serum and urine of children with kidney cysts.

Authors:  Krzysztof Plesiński; Piotr Adamczyk; Elżbieta Świętochowska; Aurelia Morawiec-Knysak; Aleksandra Gliwińska; Omar Bjanid; Maria Szczepańska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2019 Jul-Sep       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.